Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo
Objective: Single-nucleotide polymorphisms in the FTO gene encoding an m6Am and an m6A demethylase are associated with obesity. Moreover, recent studies have linked a dysregulation of m6A modifications and its machinery, including FTO, to the development of several forms of cancers. However, the fun...
Saved in:
Main Authors: | Melanie J. Mittenbühler (Author), Katarzyna Saedler (Author), Hendrik Nolte (Author), Lara Kern (Author), Jun Zhou (Author), Shu-Bing Qian (Author), Lydia Meder (Author), Roland T. Ullrich (Author), Jens C. Brüning (Author), F. Thomas Wunderlich (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma
by: Melanie J. Mittenbühler, et al.
Published: (2018) -
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022) -
Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
by: Le Wu, et al.
Published: (2021) -
Performance of HCC diagnosis in the KLCA-NCC guidelines: a closer look at MRI contrast agents and HCC imaging hallmarks
by: Ji Hye Min, et al.
Published: (2024) -
The potential of mRNA vaccine in HCC treatment
by: Rui Han
Published: (2023)